Edition:
United States

Evoke Pharma Inc (EVOK.OQ)

EVOK.OQ on NASDAQ Stock Exchange Capital Market

2.11USD
16 Feb 2018
Change (% chg)

$0.04 (+1.93%)
Prev Close
$2.07
Open
$2.10
Day's High
$2.13
Day's Low
$2.09
Volume
55,235
Avg. Vol
39,721
52-wk High
$4.09
52-wk Low
$2.07

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.342
Jun '17 0.00 -0.106
Mar '17 0.00 -0.373
FY 2016 Dec '16 0.00 -0.124
Sep '16 0.00 -0.285
Jun '16 0.00 -0.412
Mar '16 0.00 -0.450
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 0.00 0.00 0.00 --
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 4 18.95 75.80 0.00 18.95
Earnings (per share)
Quarter Ending Mar-18 3 -0.14 -0.10 -0.17 --
Quarter Ending Jun-18 3 -0.13 -0.09 -0.17 --
Year Ending Dec-18 5 -0.21 1.16 -0.66 0.24
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.03 34.43
P/E High - Last 5 Yrs. -- 41.47 46.75
P/E Low - Last 5 Yrs. -- 23.35 24.14
Beta 1.45 0.81 0.81
Price to Sales (TTM) -- 6.26 8.57
Price to Book (MRQ) 15.64 4.27 5.14
Price to Tangible Book (MRQ) 15.64 4.76 6.30
Price to Cash Flow (TTM) -- 22.77 25.75
% Owned Institutions 37.62 1.27 2.33

Dividends

  Company industry sector
Dividend Yield -- 1.61 1.52
Dividend Yield - 5 Year Avg -- 2.15 2.01
Dividend 5 Year Growth Rate -- 4.26 5.27
Payout Ratio(TTM) -- 45.36 42.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 8.53 9.45
Sales (TTM) vs TTM 1 Yr. Ago -- 6.35 7.30
Sales - 5 Yr. Growth Rate -- 9.90 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago -19.83 16.64 20.15
EPS (TTM) vs TTM 1 Yr. Ago 37.62 -- --
EPS - 5 Yr. Growth Rate -- 10.39 11.48
Capital Spending - 5 Yr. Growth Rate -- 14.63 14.76

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.38 2.42
Current Ratio (MRQ) 4.06 3.33 3.38
LT Debt to Equity (MRQ) 0.00 8.98 11.85
Total Debt to Equity (MRQ) 0.00 12.06 15.12
Interest Coverage (TTM) -31.54 44.83 38.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.25 54.90
Gross Margin - 5 Yr. Avg. -- 52.61 52.64
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.52 9.86
Operating Margin (TTM) -- 11.43 1.25
Operating Margin - 5 Yr. Avg. -- 14.30 5.07
Pre-Tax Margin (TTM) -- 11.82 2.12
Pre-Tax Margin - 5 Yr. Avg. -- 14.58 5.33
Net Profit Margin (TTM) -- 8.21 -1.38
Net Profit Margin - 5 Yr. Avg. -- 10.92 1.62
Effective Tax Rate (TTM) -- 22.39 22.03
Effective Tax Rate - 5 Yr. Avg. -- 23.57 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 919,747,049 819,569,446
Net Income/Employee (TTM) -1,921,201 107,578,762 95,804,981
Receivable Turnover (TTM) -- 5.29 5.40
Inventory Turnover (TTM) -- 2.59 3.48
Asset Turnover (TTM) 0.00 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -124.68 11.11 10.68
Return on Assets - 5 Yr. Avg. -74.54 12.64 12.00
Return on Investment (TTM) -150.16 14.00 13.54
Return on Investment - 5 Yr. Avg. -86.15 16.55 15.72
Return on Equity (TTM) -397.72 15.34 14.80
Return on Equity - 5 Yr. Avg. -565.58 17.61 16.91
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 38.41 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Evoke Pharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 37.62%
# of Holders: 37
Total Shares Held: 5,799,095
3 Mo. Net Change: 750,660
# New Positions: 11
# Closed Positions: 4
# Increased Positions: 17
# Reduced Positions: 9
# Net Buyers: 8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.